PCT’s Experts Will Be At the Cell & Gene Therapy World Phacilitate 2018 Event to Hear From You
PCT Team | November 27, 2017
Each year, Cell & Gene Therapy World hosts “The world’s only whole-ecosystem partnering event for the cell & gene therapy industry,” Phacilitate 2018. At this event, over 100 exhibitors and 1,200 attendees will meet at the Hyatt Regency in Miami, Florida to discuss the future of cell and gene therapy, including new technology and functional areas that contribute to successful commercialization.
As a leader in the field of cell therapy development, Hitachi Chemical Advanced Therapeutics Solutions (HCATS) was invited to the Phacilitate event to join several panel discussions starting on Tuesday, January 23, 2018!
What to Look Forward to at Phacilitate 2018
Panel Discussions With Industry Experts and Developers:
HCATS’ leadership will be joining and/or leading three different panel discussions for the Phacilitate event from the 23rd to the 25th of January.
The first panel discussion “How are CMO consolidation trends and business/collaboration models set to evolve (e.g. the ‘one-stop’ shop)?” will be held at 2:05 pm on Tuesday the 23rd. Sanjin Zvonic, Phd, Senior Director and Business Leader for Clinical and Commercial Cell Therapy Manufacturing will be presenting on this panel.
The second panel discussion on “What is the desired future state for contract manufacturing for cell therapy?” will be held on Wednesday, January 24th at 11:15 am. Dr. Zvonic will be moderating this panel.
The third and final panel discussion HCATS will be leading is “Cell & Gene Therapy World in Summary: Highlights and Trends from This Year’s Event.” This recap of the Phacilitate 2018 event will feature the HCATS team presenting analysis on the hot topics of the event and the direction of the industry. The discussion will be held on Thursday, January 25 at 1:00 pm.
Aside from joining these panel discussions, HCATS will also be exhibiting at Phacilitate 2018. This exhibit will consist of a 200 sq. ft. space in the main exhibition area. Our team can also meet in a dedicated private boardroom for the duration of the conference.
The experts from HCATS will be at the exhibition area to discuss the needs and challenges of cell therapy developers, the evolution of our PCT service platform, and strategies for overcoming the challenges of commercializing cell therapies.
Why You Should Attend
1. To Network with the Other Attendees
With over 1,200 attendees and 100+ exhibitors, the Phacilitate event represents a tremendous networking opportunity for all kinds of organizations interested in cell therapy development! Whether you’re part of a research institution, a cell therapy development unit in a pharmaceutical company, or a supplier of equipment used in therapy R&D, there’s someone at Phacilitate to network with.
2. To Get Insights into the Latest Therapy Trends
HCATS isn’t the only organization holding exhibits and participating in panel discussions. With over 200 speakers sharing their insights at the event, there will be ample opportunity to learn about the trends in cell and gene therapy development, such as automation, cryopreservation, and the use of cord blood and perinatal stem cells.
Register for the Conference Today!
Because PCT is a Gold Sponsor for the event, the organizers are offering our clients an exclusive 25% discount on conference registrations! However, this is a limited-availability offer for our clients, so be sure to contact us today if you’re interested in going!
To learn more about getting started on the road to manufacturing, download our ebook below.
PCT TeamOur leaders have worked on some of the major cell therapies of the past 10 years, and have extensive experience in pharmaceutical-grade quality and operations.
Subscribe to our blog for instant updates on challenges and trends in cell therapy development, manufacturing and commercialization.